Eastbourne Capital Management Llc Ca, Ten Percent Owner at Sarepta Therapeutics, holds 5.66M shares in Sarepta Therapeutics (Ticker: SRPT), holds 3.23M shares in Cassava Sciences (Ticker: SAVA), holds 10.30M shares in MGIC Investment (Ticker: MTG). Most recently, Eastbourne Capital Management Llc Ca Sold ― shares of Sarepta Therapeutics on Mar 08, 2010 for an estimated value of 5.08M.